Wu H, Liu X, Jaenisch R
Whitehead Institute for Biomedical Research, Cambridge, MA 02142.
Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2819-23. doi: 10.1073/pnas.91.7.2819.
A subtle mutation that rendered type I collagen resistant to mammalian collagenase has been introduced into the murine Col1a-1 (recently redesignated Cola-1) gene by homologous recombination in embryonic stem (ES) cells. Initially, a "hit and run" procedure was used. Since two steps were required for introducing each mutation and more than one mutation was to be introduced in the same genomic region independently, we have developed a streamlined procedure that involves two sequential replacement-type homologous recombination events. In the first step, an internal deletion was introduced into the Col1a-1 locus along with the positive and negative selectable markers, neo and tk, to mark the region of interest. G418-resistant homologous recombinants were isolated and used in the second step in which the deleted Col1a-1 allele was replaced with a construct containing the desired mutation. Homologous recombinants containing the mutation were identified among the Tk- ES clones after selection with FIAU [1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodouracil (called fialuridine)]. Approximately 10% of such clones contained the desired mutation. The double replacement procedure greatly reduces the time and amount of work required to introduce mutations independently into the same or closely linked regions. Once the homologous recombinants derived from the first step are established, the introduction of other mutations into the deleted region becomes a one-step procedure. For X number of introduced mutations, 2X selections are required with the "hit and run" approach, but only X + 1 are required with the double-replacement method. This innovative procedure could be very useful in studies of gene structure and function as well as gene expression and regulation.
通过胚胎干细胞(ES细胞)中的同源重组,一种使I型胶原蛋白对哺乳动物胶原酶具有抗性的微小突变已被引入小鼠Col1a-1(最近重新命名为Cola-1)基因。最初,使用了“打了就跑”程序。由于在同一基因组区域独立引入每个突变需要两个步骤,并且要引入不止一个突变,我们开发了一种简化程序,该程序涉及两个连续的置换型同源重组事件。第一步,将内部缺失连同阳性和阴性选择标记neo和tk引入Col1a-1基因座,以标记感兴趣的区域。分离出对G418有抗性的同源重组体,并在第二步中使用,在第二步中,将缺失的Col1a-1等位基因替换为含有所需突变的构建体。在用FIAU [1-(2-脱氧-2-氟-β-D-阿拉伯呋喃糖基)-5-碘尿嘧啶(称为氟尿苷)] 选择后,在Tk- ES克隆中鉴定出含有该突变的同源重组体。大约10%的此类克隆含有所需突变。双置换程序大大减少了将突变独立引入同一或紧密连锁区域所需的时间和工作量。一旦建立了第一步产生的同源重组体,将其他突变引入缺失区域就变成了一步程序。对于X个引入的突变,“打了就跑”方法需要进行2X次选择,但双置换方法只需要X + 1次选择。这种创新程序在基因结构和功能以及基因表达和调控的研究中可能非常有用。